Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599635 · ClinicalTrials.gov registry record · Phase 4
Pec Infiltration With Liposomal Bupivacaine for Breast Surgery
A Phase 4 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
NCT03599635 is a Phase 4 study that has completed, run by University of Minnesota. The registered enrollment target is 112 participants.
The verdict
NCT03599635, a Phase 4 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
Study Summary
The purpose of this study is to compare pain control after breast surgery using either liposomal bupivacaine or bupivacaine when infiltrated during an ultrasound guided pectoralis 1 and 2 block. Both medications, liposomal bupivacaine and bupivacaine, are standard of care in these types of surgeries.
Interventions
- DRUG Bupivacaine
- DRUG liposomal bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2024-07-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03599635
The ClinicalTrials.gov registry entry for NCT03599635 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03599635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03599635 about?
NCT03599635 is a clinical study titled "Pec Infiltration With Liposomal Bupivacaine for Breast Surgery". The purpose of this study is to compare pain control after breast surgery using either liposomal bupivacaine or bupivacaine when infiltrated during an ultrasound guided pectoralis 1 and 2 block. Both medications, liposomal bupivacaine and bupivacaine, are standard of care in these types of surgeries...
What is the current status of trial NCT03599635?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2018-07-01. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT03599635?
The interventions under investigation include: Bupivacaine (DRUG), liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03599635?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.